We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+21%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$2.69B
AUM Growth
-$3.13B
Cap. Flow
-$3.39B
Cap. Flow %
-126.08%
Top 10 Hldgs %
46.1%
Holding
425
New
193
Increased
27
Reduced
64
Closed
119

Top Sells

Rank Stock Value
1
BBIO icon
BridgeBio Pharma
BBIO
+$23.1M
2
TXN icon
Texas Instruments
TXN
+$19M
3
MA icon
Mastercard
MA
+$16.8M
4
BLK icon
Blackrock
BLK
+$15.5M
5
WFC icon
Wells Fargo
WFC
+$12.8M

Sector Composition

Rank Sector Weight
1 Communication Services 15.3%
2 Healthcare 13.97%
3 Technology 10.75%
4 Industrials 5.38%
5 Financials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
126
Microchip Technology
MCHP
$46B
$1.02M 0.04%
16,000
-17,501
-52% -$1.08M
VERA icon
127
Vera Therapeutics
VERA
$2.36B
$1.01M 0.04%
+20,000
New +$710K
VRTX icon
128
Vertex Pharmaceuticals
VRTX
$126B
$997K 0.04%
+2,200
New +$948K
HON icon
129
Honeywell
HON
$78B
$995K 0.04%
5,100
-56,114
-92% -$11M
MAR icon
130
Marriott International
MAR
$92.3B
$993K 0.04%
+3,200
New +$914K
QCOM icon
131
Qualcomm
QCOM
$176B
$992K 0.04%
+5,800
New +$994K
ABNB icon
132
Airbnb
ABNB
$107B
$991K 0.04%
+7,300
New +$909K
TER icon
133
Teradyne
TER
$59.3B
$987K 0.04%
+5,100
New +$875K
AMGN icon
134
Amgen
AMGN
$222B
$982K 0.04%
+3,000
New +$952K
ROP icon
135
Roper Technologies
ROP
$39.8B
$979K 0.04%
+2,200
New +$1.02M
ADSK icon
136
Autodesk
ADSK
$52.6B
$977K 0.04%
+3,300
New +$998K
NXPI icon
137
NXP Semiconductors
NXPI
$60.4B
$977K 0.04%
+4,500
New +$965K
VRT icon
138
Vertiv
VRT
$105B
$972K 0.04%
+6,000
New +$1.04M
AXON
139
Axon Enterprise
AXON
$46.4B
$965K 0.04%
+1,700
New +$1.05M
MS icon
140
Morgan Stanley
MS
$340B
$933K 0.03%
5,254
-18,091
-77% -$3.02M
GFS icon
141
GlobalFoundries
GFS
$29.6B
$903K 0.03%
+25,866
New +$920K
MLKN icon
142
MillerKnoll
MLKN
$1.67B
$894K 0.03%
+48,881
New +$797K
BIIB icon
143
Biogen
BIIB
$30.7B
$886K 0.03%
+5,033
New +$822K
JEF icon
144
Jefferies Financial Group
JEF
$13.1B
$879K 0.03%
14,180
-68,495
-83% -$3.93M
UNF icon
145
Unifirst Corp
UNF
$5.25B
$874K 0.03%
+4,533
New +$765K
WERN icon
146
Werner Enterprises
WERN
$2.25B
$868K 0.03%
+28,926
New +$795K
AMRZ
147
Amrize Ltd
AMRZ
$25.8B
$865K 0.03%
+16,000
New +$816K
URBN icon
148
Urban Outfitters
URBN
$6.59B
$858K 0.03%
+11,394
New +$806K
CTRI icon
149
Centuri Holdings
CTRI
$2.41B
$851K 0.03%
+33,700
New +$753K
CWAN
150
DELISTED
Clearwater Analytics
CWAN
$846K 0.03%
+35,066
New +$702K

Similar funds

Laurion Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Laurion Capital Management held 425 positions worth $2.69B, down 54% from $5.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Laurion Capital Management withdrew a net $3.39B in Q4 2025, closing 119 positions and reducing 64 holdings. Its most notable exit was Mastercard, an estimated $16.8M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 15% of assets, up from 1% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Laurion Capital Management opened a new position in Alphabet (Google) Class A worth $143M.

  • Laurion Capital Management's largest Q4 2025 buy was Alphabet (Google) Class A: 456,343 shares worth $143M.
  • Laurion Capital Management added most to Alphabet (Google) Class C in Q4 2025, an estimated $89M increase.
  • Laurion Capital Management's biggest Q4 2025 reduction was BridgeBio Pharma, cutting an estimated $23.1M.
  • Laurion Capital Management fully exited Mastercard in Q4 2025, selling an estimated $16.8M.
  • Laurion Capital Management's ten largest holdings make up 46% of its $2.69B portfolio in Q4 2025.
  • Laurion Capital Management opened 193 new positions and closed 119 in Q4 2025.
  • Laurion Capital Management's portfolio value fell 54% quarter-over-quarter to $2.69B.

Based on Laurion Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.